SAN DIEGO, Dec. 21, 2012 /PRNewswire/ -- Synteract, Inc., a full-service contract research organization (CRO), will be attending two upcoming West Coast conferences in January, J.P. Morgan 31st Annual Healthcare Conference and Outsourcing in Clinical Trials West Coast.
(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)
The J.P. Morgan 31st Annual Healthcare Conference will take place at Hotel Nikko in San Francisco, from January 7-11, 2013. Synteract is sponsoring an exclusive executive breakfast during the conference on January 9 at 7:30 a.m. PST. At the “Big Data Biopharma Forum” breakfast, presented by Fierce Biotech, Executive Editor Ryan McBride and a panel of industry experts will discuss the challenges inherent in the phenomena of dealing with more analytics data and tools than have ever been available before in drug development. The breakfast presents attendees with the opportunity to gain insider perspectives and to network with peers.
Topics of discussion will include:
- Current and future impacts of Big Data in drug development
- Intelligently advancing drug research with new IT advances
- Insights on new biotech ventures leveraging computational and analytical capabilities
- Analyses on the role of vendors and service partners in supporting research
The Outsourcing in Clinical Trials West Coast conference will take place January 29-30, 2013 at the Hyatt Regency San Francisco Airport Hotel. Barbara Ruby, associate project director at Synteract will speak on successful collaboration between a CRO and a sponsor on January 29 at 3:45 p.m. PST. Specific areas of discussion will include establishing goals, preparing for success, being accountable, knowing your team and more. Synteract will exhibit at booth #52 where they will discuss their Shared Work Shared Vision approach to business.
Outsourcing in Clinical Trials conferences are a series of industry events presenting the most pressing issues and providing solutions to numerous challenges in clinical trial outsourcing. This networking opportunity brings together industry professionals who are looking for innovative strategies to manage the complexities in the drug development landscape.
To set up an appointment in advance, contact Matt Smith, SVP Sales and Marketing at (760) 268-8200.
About Synteract (www.synteract.com)
Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With its “Shared Work Shared Vision” philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology.
CONTACT:
Antonia Genov
Clearpoint Agency, for Synteract
antonia@clearpointagency.com
760-230-2424
SOURCE Synteract, Inc.
